Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04362085
Recruitment Status : Completed
First Posted : April 24, 2020
Last Update Posted : October 26, 2021
Sponsor:
Collaborators:
University of Vermont Medical Center
University of Sao Paulo
Hôpital Charles Lemoyne
William Osler Health System
MOUNT SINAI HOSPITAL
Trillium Health Partners
St. Joseph's Health Centre
The Ottawa Hospital
Hopital du Sacre-Coeur de Montreal
Michael Garron Hospital
University of Alberta
Southlake Regional Health Centre
Hospital Maisonneuve-Rosemont
Queen Elizabeth II Health Sciences Centre
Foothills Medical Centre
Rockyview General Hospital
Peter Lougheed Centre
Mater Misericordiae University Hospital
King Saud University Medical City
King Fahad Medical City
King Faisal Specialist Hospital
Versiti
Barnes-Jewish Hospital
Al Ain Hospital
Information provided by (Responsible Party):
Unity Health Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 10, 2021
Actual Study Completion Date : October 14, 2021
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):